scispace - formally typeset
B

Brian P. Danysh

Researcher at Broad Institute

Publications -  37
Citations -  1070

Brian P. Danysh is an academic researcher from Broad Institute. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 12, co-authored 21 publications receiving 696 citations. Previous affiliations of Brian P. Danysh include Rice University & University of Texas MD Anderson Cancer Center.

Papers
More filters
Journal ArticleDOI

Distinct cellular dynamics associated with response to CAR-T therapy for refractory B cell lymphoma

TL;DR: In this article , the authors performed single-cell transcriptome sequencing of 105 pretreatment and post-treatment peripheral blood mononuclear cell samples, and infusion products collected from 32 individuals with large B cell lymphoma treated with either of two CD19 CAR-T products: axicabtagene ciloleucel (axi-cel) or tisagenlecleucel(tisa-cel).
Journal ArticleDOI

Transmembrane mucins as novel therapeutic targets.

TL;DR: Rises in the normally low levels of mucin fragments in serum have been used as markers of disease, such as tumor burden, for many years and several approaches are being examined that target mucins for immunization or nanomedicine using mucin-specific antibodies.
Journal ArticleDOI

The Transcription Factor ETV5 Mediates BRAFV600E-Induced Proliferation and TWIST1 Expression in Papillary Thyroid Cancer Cells.

TL;DR: It is found that ETV5 is critical for PTC cell growth, is expressed downstream of the MAPK pathway, and directly upregulates the transcription factor TWIST1, a known marker of intravasation and metastasis.
Journal ArticleDOI

Ponatinib Activates an Inflammatory Response in Endothelial Cells via ERK5 SUMOylation.

TL;DR: A novel mechanism by which ponatinib up-regulates endothelial ERK5 SUMOylation and shifts ECs to an inflammatory phenotype, disrupting vascular homeostasis is proposed.
Journal ArticleDOI

The MUC1 Ectodomain: A Novel and Efficient Target for Gold Nanoparticle Clustering and Vapor Nanobubble Generation.

TL;DR: The results demonstrate the promising opportunities MUC1 offers to improve the efficacy of targeted nanoparticle based approaches and their subsequent vapor nanobubble generation efficacy in the human epithelial cell line, HES.